Hoffman Robert E. Insider Trades

Insider Trading History

Track insider trading activity for Hoffman Robert E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Esperion Therapeutics
Esperion Therapeutics ESPR
Director
Holding Value $269k 85,153 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 79,873 shares
$3.13
$3.16
FibroBiologics
FibroBiologics FBLG
Director
Holding Value $16.5k 22,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.1k 22,000 shares
$0.87
$0.75
Esperion Therapeutics
Esperion Therapeutics ESPR
Director
Holding Value $22.2k 7,040 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.12k 7,040 shares
$0.87
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
Director
Holding Value $126k 40,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.4k 40,000 shares
$1.41
$3.16
Kintara Therapeutics
Kintara Therapeutics KTRA
President, CEO And Interim CFO
Holding Value $4.98k 23,142 shares
Last Trade
Aug 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.77M 23,142 shares
$162.93
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
President, Ceo, And CFO
Holding Value $14.8k 68,902 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.5M 59,800 shares
$108.64
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
President And CEO
Holding Value $259k 1,200,634 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$369M 1,200,634 shares
$307.47
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
President And CEO
Holding Value $11.8k 55,000 shares
Last Trade
Feb 15, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44.9M 55,000 shares
$815.50
$0.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up